Cardiac cell therapy which, until recently, was presented as cutting edge treatment is currently being put into perspective in the scientific press. With a race against the clock between research using adult stem cells and that using embryo stem cells, varying, even contradictory results have emerged.
At the same time, a study was published in The Cochrane Library highlighting the positive aspects of the clinical trial with a view to treating cardiac patients with adult bone marrow stem cells.
As far as Dr. Enca Martin-Rendon, stem cell scientist at Oxford University, is concerned:
It is difficult to reach concrete conclusions when clinical trials focusing on larger samples and taking long-term effects into account have not been carried out to date”.
N.B.: In the next monthly issue of Gènéthique, the current status of cardiac cell therapy research will be unveiled to subscribers. Visit the following website to subscribe: firstname.lastname@example.org